Tygh Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $6.76M | Sell |
|
|||||
|
2021
Q2 | $7.33M | Sell |
|
|||||
|
2021
Q1 | $5.8M | Sell |
|
|||||
|
2020
Q4 | $5.83M | Sell |
|
|||||
|
2020
Q3 | $7.91M | Sell |
|
|||||
|
2020
Q2 | $11M | Sell |
|
|||||
|
2020
Q1 | $8.47M | Buy |
|
|||||
|
2019
Q4 | $10.2M | Sell |
|
|||||
|
2019
Q3 | $8.9M | Buy |
|
|||||
|
2019
Q2 | $4.38M | Sell |
|
|||||
|
2019
Q1 | $6.16M | Sell |
|
|||||
|
2018
Q4 | $7.65M | Buy |
|
|||||
|
2018
Q3 | $7M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $7.04M | Buy |
|
|||||
|
2017
Q3 | $3.9M | Sell |
|
|||||
|
2017
Q2 | $5.12M | Sell |
|
|||||
|
2017
Q1 | $5.56M | Buy |
|
|||||
|
2016
Q4 | $2.35M | Buy |
|